Home Tags Pharmaceuticals

Tag: Pharmaceuticals

US: Celgene settles class action for $55M

US biotech company Celgene has agreed to pay a US$55 million settlement after it was accused of illegally maintaining a monopoly over the market...
Roche logo

US: Roche extends Spark buyout deadline

Roche and Spark Therapeutics’ road to a US$4.3 billion merger has been a rocky one, with various delays pushing the long-gestating agreement back four...

What the Servier judgment teaches us about market definition under...

February 2019 CPI EU News Column edited by Thibault Schrepel, Sam Sadden & Jan Roth (CPI) presents: What the Servier judgment1 teaches us about market definition under...

Excessive Pricing in Pharmaceutical Markets

January 2019 CPI Europe Column edited by Anna Tzanaki (Competition Policy International) & Juan Delgado (Global Economics Group) presents: Excessive Pricing in Pharmaceutical Markets By Pedro Caro de Sousa (OECD)1 Introduction This...

US: California AG sues Abbvie for illegal kickbacks

Pharmaceutical company Abbvie had its shares drop about 3% last week after California’s insurance commissioner Dave Jones sued the company, alleging Abbvie has been...

US: Pay-for-delay lawsuit settled for US$270m

Endo International Plc, Teva Pharmaceuticals and Teikoku Seijaku have agreed to pay a cumulative US$270.8 million to resolve class action lawsuits alleging Endo paid...

Innovation and the Firm: A New Synthesis

Posted by Social Science Research Network Innovation and the Firm: A New Synthesis By Peter Lee (University of California) Abstract:       Recent scholarship highlights the...

EU: Commission objects to Teva-Cephalon “pay-for-delay”

The European Commission has informed pharmaceutical company Teva of its preliminary view that an agreement concluded with Cephalon was in breach of EU antitrust...

US: West Virginia joins multi-state price fixing law suit

West Virginia Attorney General Patrick Morrisey joined a multistate lawsuit alleging antitrust violations involving an antibiotic, an oral diabetes medication and six generic drug...

US: Ranbaxy pay-for-delay trial starts

As complex as reverse-payment antitrust lawsuits can be, the one being litigated against generic drug maker Ranbaxy over its settlement with Cephalon can be...

News

Antitrust Mix by CPI